Loading…
Based on limited metadata, the FDA issued a warning letter to Camelot E-Liquid on March 6, 2019, regarding tobacco products. Without access to the full warning letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter falls under FDA's tobacco product regulatory scope, though the specific issuing office is not identified in the metadata provided.